• 2022.11.10

Poster Presentations at SITC 2022

Details of the poster presentations are as follows:

Title: Combination of Lemzoparlimab and HER2 ADC Elicits Enhanced Activity against HER2 Expressing Tumors
Abstract ID: 859
Presenter: Dr. Fanny Zhang, I-Mab
Date/Time: Thursday, November 10, 2022, 9:00 a.m. – 9:00 p.m. ET

 

Title: Revealing Novel Immune Modulatory Mechanism of Uliledlimab through the Blockade of CD73 Pathway
Abstract ID: 1151
Presenter: Dr. Fanny Zhang, I-Mab
Date/Time: Thursday, November 10, 2022, 9:00 a.m. – 9:00 p.m. ET

 

Full text of the abstracts will be released on the SITC website at 8:00 a.m. ET on Monday, November 7, 2022, and the posters will be available on the Company’s website on November 12, 2022.